Testing effectiveness (Phase 2)Study completedNCT04855721
What this trial is testing
A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)
Who this might be right for
Plaque Psoriasis
Aurigene Discovery Technologies Limited 141
Showing 6 of 6 results